With ever evolving regulations and the rising number of unsolicited requests from increasingly well informed patients, Pharma must be prepared for any eventuality. However, these obstacles can arise at any time during a Pre-Approved Access Programme, from the point of setting objectives in the early planning stages, to the strategic logistical decisions, or navigating the highly diverse European regulatory landscape through to offering Post-Trial Access Programmes and other operational challenges. The Early and Managed Access Programmes Europe forum brings together over 60 industry leaders to share end-to-end, best practice strategies, to ensure you can fulfil your patients unmet medical needs.